Real-world data from the oncosys-OVA clinical trial (NCT06117384) - experiences on genomic and functional HRD testing and molecular determinants of progression during PARP inhibitor treatment

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Anni Härkönen, Matilda Salko, Fernando Pérez, Sanna Pikkusaari, Anni Virtanen, Heini J. Lassus, Liisa Kauppi, Ulla‐Maija Haltia, Anniina Färkkilä
DOI: 10.1016/j.ijgc.2025.103929
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy BRCA gene mutations in cancer Ovarian cancer diagnosis and treatment

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103929–103929
Publication date
1 February 2026
Language
EN